Fang Fang,CEO of Abimmune Biopharma, Inc., San Diego, U.S.A. She received close to $100M government grants; brought a first-in-class drug (Fludase) from a pure concept to saving over 100 lives (including infants) under the FDA emergency use authorization; received "Scientific American 50" Award. After close to 10 clinical trials, Fludase was granted “Breakthrough and Fast Track” status by the FDA for the indication of Para-Influenza for which no drug or vaccine is available.于2016年3月17-18日受邀参加了2016年皇后镇分子生物学（上海）会议，并以"From a pure concept to a first-in-class live saving drug and more”为题目，发表了精彩的演讲。
活动家作为专业第三方嘉宾邀约平台，依托互联网公开数据为您提供嘉宾信息展示服务。若您发现嘉宾信息需要更新或移除，请发送邮件或联系客服。
我们专注于根据您的具体需求（包括演讲议题、会议日期及活动预算等），为您精准匹配各领域专业嘉宾。为高效服务，建议您提前准备好详细活动信息，并拨打客服电话：18911802888（工作日9:00-18:00）。
温馨提示：本服务仅限嘉宾邀约相关事宜，其他需求暂不处理，感谢您的理解与配合。